Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
NCT Number: NCT03903965
This study aims to compare the retinal perfusion between diabetic and non-diabetic patients with Optical Coherence Tomography(OCT) Angiography after cataract surgery, to thoroughly evaluate the retinal state of diabetics after surgery, and to find out the relationship between postoperative complications occurred in retina and diabetes.
Looking for future studies?
Notify Me50 year–80 year
All sexes
Observational
Beijing, Beijing Municipality, 100191, China
In this study, we perform a completely comparison of retina state characteristic including the foveal avascular zone(FAZ),perifovea vessel density,parafovea vessel density,macular thickness,perifovea thickness,parafovea thickness in superficial and deep layers of retina with OCT Angiography after cataract surgery,and analysis on the differences of EGF,IFN-γ,IL-10,IL-12,IL-1β,IL-6,IL-8,IP-10,MCP-1,VEGF in aqueous humor before surgery between diabetic and non-diabetic patients and to explore the potential correlations between postoperative complications occurred in retina and diabetes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Elimination Criteria:
Time frame: 3 months postoperatively
comparison of vessel density in superficial and deep layers of retina between diabetic and non-diabetic patients with OCT Angiography.
Time frame: intraoperatively.
comparison the levels of cytokines from aqueous humor including EGF,IFN-γ,IL-10,IL-12,IL-1β,IL-6,IL-8,IP-10,MCP-1,VEGF between diabetic and non-diabetic patients.
Peking University Third Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06638099
Diabetes, Diabetes Mellitus
El Centro, California, United States
View Trial DetailsNCT06769906
Behavior, Behavioral Symptoms
Seoul, South Korea
View Trial DetailsNCT06644651
Arterial Occlusive Diseases, Arteriosclerosis
Svendborg, Region Syddanmark, Denmark
View Trial DetailsNCT07016958
Atrophy, Diabetes Mellitus
Istanbul, Turkey (Türkiye)
View Trial Details